Randomized Controlled Trial of the SurgDiff Model for Predicting Surgical Difficulty to Help Choose Approach in Mid-Low Rectal Cancer

Sponsor
Peking Union Medical College Hospital
Study ID
NCT07761169
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • AI-assisted decision-making — PROCEDURE
    The SurgDiff model performs a difficulty assessment based on the patient's preoperative MRI scans and clinical data, thereby assisting the surgeon in formulating the surgical plan

Study Details

This study aims to investigate the feasibility of utilizing the SurgDiff surgical difficulty prediction model to assist surgeons in formulating precise surgical plans.

Key Dates

First listed
Aug 12, 2026
Start date
Aug 30, 2026
Status verified
Aug 2026
Primary completion
Sep 1, 2027
Completion
Sep 30, 2030

Study Design

Enrollment
68 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: experimental group
    The SurgDiff model performs a difficulty assessment based on the patient's preoperative MRI scans and clinical data, thereby assisting the surgeon in formulating the surgical plan.
  • No Intervention: control group
    The surgeon selects the surgical approach and performs the procedure

Primary Outcome Measure

Mesorectal incomplete rate [ Time Frame: 2 weeks after surgery ]

Find similar trials

Nationwide
Colorectal cancer trialsOncology trialsGI oncology trials

Related Studies